In the 891 RRBSO cases, there were 30 BRCA1 carriers (6.4%) who died during follow‐up, six due to ovarian cancer, five of whom were diagnosed at RRBSO, including three Stage 1 cancers and one post RRBSO PPC. Here, BRCA1 is linked to ovarian cancer.